|Articles|July 1, 1998

July 1998
Volume 4
Issue 7

Treatment Options for Prostate Cancer: Part 1--Stage, Grade, PSA, and Changes in the 1990's

Author(s)LTC Judd W. Moul, MD, MC, USA

Download PDF: Treatment Options for Prostate Cancer: Part 1--Stage, Grade, PSA, and Changes in the 1990's

Articles in this issue

over 27 years ago

Article

A New Method of Developing Expert Consensus Practice Guidelines

over 27 years ago

Article

Patient Consultation in a Managed Care Setting: Guiding Pharmacy into the Future

over 27 years ago

Article

Should Clinicians Rely on Expert Opinion or Empirical Findings?

over 27 years ago

Article

Compliance with Anti-Hypertensive Therapy: Raising the Bar of Expectations

over 27 years ago

Article

In Vitro and Skin Testing for Allergy: Comparable Clinical Utility and Costs

over 27 years ago

Article

Impact of Pharmacist Consultations Provided to Patients with Diabetes on Healthcare Costs in a Health Maintenance Organization

over 27 years ago

Article

The Cost-Effectiveness of Treatment with Lamivudine and Zidovudine Compared with Zidovudine Alone: A Comparison of Markov Model and Trial Data Estimates

over 27 years ago

Article

Introducing Managed Care to the Medical School Curriculum: Effect on Student Attitudes

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

ByMohamed M. Ali, MS,Scott Lunos, MS,Zachary Henderson, BSB,Michele Allen, MD, MS,Patricia Adam, MD, MSPH,Genevieve B. Melton, MD, PhD,Rubina Rizvi, MD, PhD

January 12th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Treatment Options for Prostate Cancer: Part 1--Stage, Grade, PSA, and Changes in the 1990's

Articles in this issue

Newsletter

Related Content

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

CRC Becomes Leading Cause of Cancer-Related Death in Younger Adults, Highlighting Prevention Gaps

Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns

Novel CLL Therapies Prompt New Treatment Considerations

5 Ongoing Phase 3 Trials in Hematologic Malignancies

ACE Inhibitors Linked to Reduced Mortality in Patients with Idiopathic Pulmonary Fibrosis